Transparency

Our mission is to make medicines that help people live longer, healthier, more active lives. To achieve this mission, Lilly works with various individuals and organizations to improve patient outcomes and the healthcare system.

We are proud of the support we provide in collaboration with others to help advance the treatment and care of those battling illnesses. We also believe transparency is critical to rebuilding trust in our industry. Lilly was the first company (in 2004) to establish an online database of our clinical trial results, and the first company (in 2007) to establish a public registry of our grants and charitable contributions. And, in 2009, we became the first company to report our payments to physicians for speaking and advising services. Lilly strives to be a leading voice and example in transparency efforts in the biopharmaceutical industry.

Lilly Clinical Trial Registry

In 2004, Lilly became the first company to voluntarily make public or U.S. clinical trials and our clinical trials data in the Lilly Clinical Trial Registry.

Lilly Public Affairs & Political Contributions

Lilly supports candidates of any party who support public policies that contribute to pharmaceutical innovation and health needs of patients.  Eligible Lilly employees in the U.S. may choose to make voluntary contributions to the Lilly Political Action Committee (PAC), an entity funded solely by employee contributions.  For more information, view our contribution reports.

Lilly Physician Payment Registry

When doctors work together with the pharmaceutical industry, patients benefit - because collaboration makes new medicines possible, delivers quality health education, and provides better insights into unmet patient needs.  Lilly is now tracking aspects of our financial relationships with physicians in the U.S. as required by a Corporate Integrity Agreement we entered into with the Office of the Inspector General of the U.S. Department of Health and Human Services in February 2009.  Lilly discloses payments and other types of value provided to all U.S.-based physicians in the Physician Payment Registry.  To learn more, visit the Lilly Physician Payment Registry website.

 

Lilly Grant Registry

In 2007, Lilly became the first biopharmaceutical company to publicly report the funding we provide in the U.S. to institutions in the form of educational grants and charitable contributions to support medical education, patient education and other worthy activities that we believe increase health care knowledge and imporove patient care.  The Lilly Grant Office administers this program.

Lilly Foundation

In keeping with the Lilly family's commitment to good corporate responsibility, Lilly contributes at the level of the most generous companies worldwide -- a goal it achieves annually through product and cash contributions.  See Lilly Foundation or see the Lilly Foundation Report on Charitable Giving.

Lilly Transparency

Researchers looking to answer questions using Lilly clinical trial data from approved medicines can request access at www.LillyClinicalStudyData.com